1) Bostock H, Cikurel K, Burke D. Threshold tracking techniques in the study of human peripheral nerve. Muscle Nerve. 1998; 21: 137-58
|
|
|
2) Kiernan MC, Burke D, Andersen KV, et al. Multiple measures of axonal excitability: a new approach in clinical testing. Muscle Nerve. 2000; 23: 399-409
|
|
|
3) Kanai K, Kuwabara S, Misawa S, et al. Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage. Brain. 2006; 129: 953-62
|
|
|
4) Vucic S, Kiernan MC. Axonal excitability properties in amyotrophic lateral sclerosis. Clin Neurophysiol. 2006; 117: 1458-66
|
|
|
5) Misawa S, Kuwabara S, Ogawara K, et al. Hyperglycemia alters refractory period in human diabetic neuropathy. Clin Neurophysiol. 2004; 115: 2525-9
|
|
|
6) Kitano Y, Kuwabara S, Misawa S, et al. The acute effects of glycemic control on axonal excitability in human diabetics. Ann Neurol. 2004; 56: 462-7
|
|
|
7) Misawa S, Kuwabara S, Ogawara K, et al. Strength-duration properties and glycemic control in human diabetic motor nerves. Clin Neurophysiol. 2005; 116: 254-8
|
|
|
8) Misawa S, Kuwabara S, Kanai K, et al. Axonal potassium conductance and glycemic control in human diabetic nerves. Clin Neurophysiol. 2005; 116: 1181-7
|
|
|
9) Misawa S, Kuwabara S, Kanai K, et al. Nodal persistent Na+ currents in human diabetic nerves estimated by the technique of latent addition. Clin Neurophysiol. 2006; 117: 815-20
|
|
|
10) Misawa S, Kuwabara S, Kanai K, et al. Aldose reductase inhibition alters nodal Na+ currents and nerve conduction in human diabetics. Neurology. 2006; 66: 1545-9
|
|
|
11) Tamura N, Kuwabara S, Misawa S, et al. Increased nodal persistent Na+ currents in human neuropathy and motor neuron disease estimated by latent addition. Clin Neurophysiol. 2006; 117: 2451-8
|
|
|
12) Brismar T, Sima AAF, Greene DA. Reversible and irreversible nodal dysfunction in diabetic neuropathy. Ann Neurol. 1987; 21: 504-7
|
|
|
13) Brismar T. Abnormal Na-currents in diabetic rat nerve nodal membrane. Diabet Med. 1993; 10(Suppl 2): S110-2
|
|
|
14) Kanai K, Kuwabara S, Arai K, et al. Muscle cramp in Machado-Joseph disease: altered motor axonal excitability properties and mexiletine treatment. Brain. 2003; 126: 965-73
|
|
|
15) Kuwabara S, Misawa S, Tamura N, et al. The effects of mexiletine on excitability properties of human median motor axons. Clin Neurophysiol. 2005; 116: 284-9
|
|
|
16) Burke D, Kiernan MC, Bostock H. Excitability of human axons. Clin Neurophysiol. 2001; 112: 1575-85
|
|
|
17) Kuwabara S, Misawa S. Axonal ionic pathophysiology in human neuropathy and motor neuron disease. Curr Neurovascular Res. 2004; 1: 269-81
|
|
|
18) Kuwabara S, Ogawara K, Sung JY, et al. Differences in membrane properties of axonal and demyelinating Guillain-Barre syndromes. Ann Neurol. 2002; 52: 180-7
|
|
|
19) Cappelen-Smith C, Kuwabara S, Lin CS, et al. Membrane properties in chronic inflammatory demyelinating polyneuropathy. Brain. 2001; 124: 2439-47
|
|
|
20) Sung JY, Kuwabara S, Kaji R, et al. Threshold electrotonus in chronic inflammatory demyelinating polyneuropathy: correlation with clinical profiles. Muscle Nerve. 2004; 29: 28-37
|
|
|
21) Kiernan MC, Guglielmi JM, Kaji R, et al. Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block. Brain. 2002; 125: 664-75
|
|
|
22) Kiernan MC, Walters RJ, Andersen KV, et al. Nerve excitability changes in chronic renal failure indicate membrane depolarization due to hyperkalaemia. Brain. 2002; 125: 1366-78
|
|
|
23) Nodera H, Bostock H, Kuwabara S, et al. Nerve excitability properties in Charcot-Marie-Tooth disease type 1A. Brain. 2004; 127: 203-11
|
|
|
24) Kiernan MC, Isbister GK, Lin CS, et al. Acute tetrodotoxin-induced neurotoxicity after ingestion of puffer fish. Ann Neurol. 2005; 57: 339-48
|
|
|
25) ミユキ技研HP http://www.miyuki-net.co.jp
|
|
|
26) Schwarz JR, Glassmeier G, Cooper EC, et al. KCNQ channels mediate IKs, a slow K+ current regulating excitability in the rat node of Ranvier. J Physiol. 2006; 573: 17-34
|
|
|
27) Kikkawa Y, Kuwabara S, Misawa S, et al. The acute effects of glycemic contron on nerve conduction. Clin Neurophysiol. 2005; 116: 270-4
|
|
|